chr2-47402996-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The variant allele was found at a frequency of 0.0000242 in 662,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000196 AC: 10AN: 509718Hom.: 0 Cov.: 5 AF XY: 0.0000221 AC XY: 6AN XY: 271778
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74500
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.-196G>A variant is located in the 5' untranslated region (5’ UTR) of the MSH2 gene. This variant results from a G to A substitution 196 bases upstream from the first translated codon. A variant at a nearby position (c.-190G>A, also known as c.-181G>A) was detected in an individual with MSI-H colorectal cancer diagnosed before age 40; a luciferase assay showed that promoter activity was decreased by 77% compared to wildtype (Shin KH et al. Cancer Res. 2002 Jan;62:38-42). This nucleotide position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at